Company Search:
Advanced Search
Sponsored Links
Takara Bio Inc Company Snapshot
Takara Bio Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Takara Bio Inc with three other companies in this sector in Japan: Shin Nippon Biomedical Laboratories Ltd (2019 sales of 15.66 billion Japanese Yen [US$143.90 million] of which 88% was Pre-Clinical Business), Morishita Jintan Co., Ltd. (10.09 billion Japanese Yen [US$92.73 million] of which 74% was Health Care Business), and Linical Company Limited (11.31 billion Japanese Yen [US$103.97 million] of which 92% was Cro Business).

Sales Analysis. Takara Bio Inc reported sales of ¥35.84 billion (US$329.38 million) for the fiscal year ending March of 2019. This represents an increase of 10.9% versus 2018, when the company's sales were ¥32.31 billion. Sales of Gene Medical Care saw an increase that was more than double the company's growth rate: sales were up 388.6% in 2019, from ¥500.00 million to ¥2.44 billion. Not all segments of Takara Bio Inc experienced an increase in sales in 2019: sales of Food and Bio Medical fell 18.8% to ¥1.82 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Takara Bio Inc
  Stock Performance Chart for Takara Bio Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): 2,051.00
(Figures in Japanese Yen)
1 Week -8.8%   13 Weeks -5.0%  
4 Weeks -10.0%   52 Weeks -17.6%  
Takara Bio Inc Key Data:
  Ticker: 4974 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 35,841,000,000
(Year Ending Jan 2020).
Employees: 1,435
  Currency: Japanese Yen Market Cap: 246,972,395,600
  Fiscal Yr Ends: March Shares Outstanding: 120,415,600
  Share Type: Common Closely Held Shares: 73,350,000
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.